跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
GEMITA® CONCENTRATE FOR SOLUTION FOR INFUSION 38MG/ML
Approved
THERAPEUTIC
GEMITA® CONCENTRATE FOR SOLUTION FOR INFUSION 38MG/ML
FRESENIUS KABI ONCOLOGY LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Feb 20, 2020
Approval ID
d219058e49cce612
Company
FRESENIUS KABI ONCOLOGY LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
d219058e49cce612
Drug Name
GEMITA® CONCENTRATE FOR SOLUTION FOR INFUSION 38MG/ML
Product Name
GEMITA® CONCENTRATE FOR SOLUTION FOR INFUSION 38MG/ML
Approval Number
SIN15887P
Approval Date
2020-02-20
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01BC05
Atc Item Name
xl 01 bc 05
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Active Ingredients
Gemcitabine Hydrochloride 43.2668mg/ml eqv to Gemcitabine
38mg/ml
GEMCITABINE HYDROCHLORIDE 43.2668 MG/ML EQV TO GEMCITABINE
38 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 20, 2020
Approval ID
d219058e49cce612
Type
Therapeutic
Back to HSA Approvals
GEMITA® CONCENTRATE FOR SOLUTION FOR INFUSION 38MG/ML - HSA Drug Approval Details
